Peter John Fellner
Director/Board Member at Ligand UK Development Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Anthony Kennedy | M | 54 | 13 years | |
| Martin Buckland | M | 69 |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | 13 years |
| Ian Garland | M | 59 |
Ligand UK Development Ltd.
 Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Development Ltd. is a company that manufactures pharmaceutical products. The company is based in Winnersh, UK.
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 12 years |
| David MacKney | M | 56 |
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Development Ltd. is a company that manufactures pharmaceutical products. The company is based in Winnersh, UK. | 10 years |
| Michael Wyzga | M | 69 | 5 years | |
| Denise Scots-Knight | M | 64 | 9 years | |
| Keyvan Djamarani | M | 63 | 14 years | |
| Bryan Farrell | M | - | 14 years | |
| Jean-Christophe Tellier | M | 65 | 13 years | |
| Anders Olof Adolf Ekblom | M | 70 | 9 years | |
| Sandford Sommer | M | - | 8 years | |
| Dame Davies | M | 73 | 10 years | |
| Deepa Pakianathan | M | 59 | 5 years | |
| Charles Berkman | M | 55 | 6 years | |
| Jonkheer Cédric van Rijckevorsel | M | 54 | 10 years | |
| Matthew Korenberg | M | 49 | 6 years | |
| Suba Krishnan | M | 59 | 4 years | |
| Christine Fox | F | 43 | 3 years | |
| Xavier Michel | M | - | 11 years | |
| Anne Marie Cairns | F | - | 17 years | |
| Matthew Foehr | M | 51 | 6 years | |
| Justin Roberts | M | - | 2 years | |
| Wills Hughes-Wilson | F | 53 | 6 years | |
| Jeremy Bender | M | 52 | 4 years | |
| Annalisa Jenkins | M | 58 | 2 years | |
| Mike Wood | M | - | 20 years | |
| Pierre Jacquet | M | 57 | 3 years | |
| Iris Löw-Friedrich | M | 63 | 18 years | |
| Michael Watson | M | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 17 years |
| Cord Dohrmann | M | 60 | 14 years | |
| Marc J. Yoskowitz | M | - | 2 years | |
| Daniel Shames | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John A. D. Slater | M | 71 | 10 years | |
| William John Jenkins | M | 77 | - | |
| Ismail Kola | M | 67 |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | 8 years |
| Merja Tuulikki Karhapää | F | 62 | - | |
| Kristian Rantala | M | 48 | 6 years | |
| John McNeil | M | - | - | |
| Alastair MacKinnon | M | 53 | 7 years | |
| Bo Jesper Hansen | M | 66 | 5 years | |
| Nick Higgins | M | 67 | 3 years | |
| Werner Lanthaler | M | 56 | 15 years | |
| Rosalyn Wilton | F | 72 | - | |
| David C. Rees | M | - |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | - |
| David Mellors | M | 56 | 7 years | |
| David John Cook | M | 57 | 3 years | |
| Inge Basteleurs | F | - | - | |
| Richard Bungay | M | 55 |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | - |
| William Burns | M | 76 | 5 years | |
| Thomas Taapken | M | 59 | 3 years | |
| John E. Fitzgerald | M | - |
Premier Research Group Ltd.
 Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | - |
| Neil Thompson | M | - |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | - |
| Lyn Leaper | M | - |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | - |
| Jean-Pierre Kinet | M | 70 | - | |
| Armand de Decker | M | - | - | |
| Nunzio Antonelli | M | - | - | |
| Kevin Kissane | M | 69 | 7 years | |
| Robert Corringham | M | - |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | 1 years |
| Norman J. Ornstein | M | - | - | |
| Peter Bains | M | 65 | 6 years | |
| Peter Herbert Kehoe | M | - | - | |
| Thomas G. Daniells | M | - | - | |
| Alexander Warnock | M | 59 | - | |
| Nigel Sheail | M | 59 | - | |
| Mohammed Khoso Baluch | M | 66 | 8 years | |
| Maria Ginman-Horrell | F | 59 | - | |
| Lisa Amster Schoenberg | F | 58 | - | |
| Andrew Jackson | M | - | 2 years | |
| Stephen Crummett | M | 59 | 8 years | |
| Chris Brinsmead | M | 64 | - | |
| Fabrice Enderlin | M | - | 9 years | |
| Walter Wenninger | M | 86 | 6 years | |
| Frank Armstrong | M | 67 | 4 years | |
| Mark McDade | M | 69 | 8 years | |
| Gerhard Mayr | M | 78 | 12 years | |
| James Manuso | M | 75 |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | 2 years |
| Thomas Fulton Wilson McKillop | M | 81 | 7 years | |
| Jörn Aldag | M | 65 | 11 years | |
| Dirk H. Ehlers | M | 63 | 6 years | |
| Barry Michael Rose | M | 79 | - | |
| Lutgart A. A. van den Berghe | M | 72 | - | |
| Thomas P. Monath | M | 83 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 14 years |
| Alison Hood | F | - | - | |
| Gordon Davis | M | 67 | 8 years | |
| Hilde Windels | F | 59 | 1 years | |
| Jonathan Glenn | M | 56 | 14 years | |
| David Lawrence | M | 61 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 3 years |
| Noreen Doyle | F | 75 | 9 years | |
| George J. Tenet | M | 71 | 2 years | |
| Stephen Roe | M | - | - | |
| John Geoffery Goddard | M | 73 | - | |
| Albrecht de Graeve | M | 69 | 14 years | |
| David Wilson | M | 61 | - | |
| Charmion Gillmore | F | - | - | |
| Flemming Ørnskov | M | 66 | - | |
| Simon Sturge | M | 65 | - | |
| Harriet Edelman | F | 68 | 5 years | |
| Adrian Maxwell Colman | M | 54 | 3 years | |
| Klaus Maleck | M | 51 | - | |
| Bill Silbey | M | 65 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 64 | 64.00% |
| Belgium | 23 | 23.00% |
| Germany | 9 | 9.00% |
| United States | 7 | 7.00% |
| Finland | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter John Fellner
- Personal Network
